British Patient Capital launches Life Sciences Investment Programme
The Life Sciences Investment Programme, previously announced by the Chancellor of the Exchequer, has opened for applications from fund managers. To be delivered by British Patient Capital, a commercial subsidiary of British Business Bank, the programme will bring more large-scale specialist UK focused fund managers to market, increasing the supply